ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
United Health Products Inc (PK)

United Health Products Inc (PK) (UEEC)

0.055
0.0019
(3.58%)
Closed January 03 3:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

UEEC News

Official News Only

UEEC Discussion

View Posts
JimmyRich JimmyRich 6 hours ago
Happy New Year to all..
First this will be the year that this happens..
Second nobody knows whatโ€™s to come on a buyout or pps basisโ€ฆ Weโ€™re heavily shorted and if we get uplisted and we get some real strong newsโ€ฆ boom this will happen fast.. nobody knows what is to come but there will be something coming this year for sure.. many people have a lot riding on this coming to fruition and have much more to gain by It happening rather than staying where we are now.. many people have a lot of time invested in this
๐Ÿ‘๏ธ0
DBnews DBnews 15 hours ago
I have owned this stock for so many years. I bought it on a whim at .09 per share. The fact that I state the truth does not make me what you say. You and many others have be trumpeting this stock for years. It will be bought out at ridiculous amounts. I hold it because I have nothing to lose in the stock, but am realistic on a potential buyout.
๐Ÿ‘๏ธ0
dogooder dogooder 2 days ago
Happy new year to all, 2024 a lost year for this stock, my wish amongst others,,is for management to get their shit together and do what they promised on the last presser.
Ceo has been horrible, he needs to step up and do his job,,get this company and its shareholders what we all know is possible.
1. Get fda to approve ide.
2.start surgeries as soon as possible.
3. Get uplisting approved.
4.secure financing
5.add experienced board members.
6. Get fda approval.
7.sell the company for cash or stock.

Might be dreaming, if I forgot something, oh well. Hopefully selling is over, losses taken , we will see over the coming days.

God bless and happy new year
๐Ÿ‘๏ธ0
dogooder dogooder 2 days ago
Happy new year to all, 2024 a lost year for this stock, my wish amongst others,,is for management to get their shit together and do what they promised on the last presser.
Ceo has been horrible, he needs to step up and do his job,,get this company and its shareholders what we all know is possible.
1. Get fda to approve ide.
2.start surgeries as soon as possible.
3. Get uplisting approved.
4.secure financing
5.add experienced board members.
6. Get fda approval.
7.sell the company for cash or stock.

Might be dreaming, if I forgot something, oh well. Hopefully selling is over, losses taken , we will see over the coming days.

God bless and happy new year
👍️ 1
trusttheman trusttheman 2 days ago
Get lost. Another paid of. Ihub troll.
๐Ÿ‘๏ธ0
trusttheman trusttheman 2 days ago
Last second tax write off sales.
๐Ÿ‘๏ธ0
rodman rodman 1 week ago
Special note on a 12/18 SEC posting.....The Wendy Bepolate Irrevocable Trust was in this Schedule 13D filing.
7.2 % is a sizeable influence to the future direction of voting shares. Indication of a coming uplisting?
$5-$10+

https://app.quotemedia.com/data/downloadFilin...2024-12-19

Merry Christmas!
🤣 1 🥱 1
DBnews DBnews 2 weeks ago
In my world of investing in stocks see stocks rise and fall on earnings and revenue. My concern is clear, a stock does not tank, as this has done, with the results it received from the trials, unless there is no confidence that the product will actually come to market. If I was an employee or management I would be buying this hand over fist unless there is not alot of hope it will actually come to market. I do not sell because this has become play money. If it does well great. If not this will not have any impact on my portfolio. Buy real stocks like AAPL, MSFT or QCOM. I have owned forever and will hope for the best ($3 per share)
👍️ 3
Waverunners Waverunners 2 weeks ago
Thanks Hoonigan. Iโ€™m not looking to debate your formula. However, please keep in mind that UHP is applying for a PMA for Gauze only.
Gauze makes up 25% of the Hemostatic market.
The rest is gels, powders etc.
The entire Hemostatic Gauze market is approximately $1 billion per year at this time.

BTW, Kevin Oโ€™Leary owns a ton of JnJ stock and itโ€™s one of his top 10 picks. Maybe he should buy up some UEEC while heโ€™s at it.
๐Ÿ‘๏ธ0
Hoonigan Hoonigan 2 weeks ago
Made a mistake should be --- If the UEEC products get 10% of the market over the next five years that is $3 billion and they have 25% earning the company is worth $750 Million. Based on the standard 5 times earnings company cost valuation that the great Kevin O'leary uses, the stock is worth $3 a share. 5% of the market it is worth $1.5 (based 250 million shares). The missing facts are percentage of earnings and market share. If you have those to facts you have a solid valuation estimate.
👎️ 1 😂 1
Hoonigan Hoonigan 2 weeks ago
Wow 7 million shares sold in the last month 57% were long holds diluting the market with shares driving down the stock price to these crazy levels. I keep buying all I can and feel liking I am stealing shares but someone needed some cash or end of year right off really bad. We all know who sold 10 million shares and was a shame they had to sell them. I am positive UEEC is rounding up some serious investors for the new year.

Surgicel Absorbable Hemostat Market Size was valued at USD 4 Billion in 2023 and is expected to reach USD 9.7 Billion by 2031
Break out that calculator and visor to double check me, I did this really quickly in my head without coffee and with a flue bug! feel free to start slinging mud, I have my roll off goggles and helmet on.

Here is a link to a recent market analysis (link!!) Surgicel Absorbable Hemostat Market Size and Projections

If the UEEC products get 10% of the market over the next five years that is $3 billion and they have 25% earning the company is worth $1.5 billion. Based on the standard 5 times earnings company cost valuation that the great Kevin O'leary uses, the stock is worth $3 a share. 5% of the market it is worth $1.5 (based 250 million shares). The missing facts are percentage of earnings and market share. If you have those to facts you have a solid valuation estimate.

Let the mud fly!!!



๐Ÿ‘๏ธ0
rodman rodman 2 weeks ago
Hopefully RFK and DOGE can rid the FDA of its in-efficiency and corruption that has been pervasive in the pharmaceutical industry for years! In the meantime here we are!
https://www.greenlight.guru/blog/fda-medical-device-approval-process
$5-$10+
👍️ 1
shoondale shoondale 2 weeks ago
If there is one iota of truth in what you state; please state why this piece of crap can't even sell over the counter in any country, anywhere on Earth. The FDA can only limit sales in the United States. It has been over a decade. Where are the over the counter sales?
๐Ÿ‘๏ธ0
shoondale shoondale 2 weeks ago
"FIRST CLAIM FOR RELIEF
Violations of Exchange Act Section IO(b) and Rule 10b-5 Thereunder
(UHP and Beplate)
SECOND CLAIM FOR RELIEF
Violations of Exchange Act Section I0(b) and Rules IOb-S(a) and (c) Thereunder
(Schiliro)
THIRD CLAIM FOR RELIEF
Aiding and Abetting Violations of Exchange Act Section lO(b) and Rule 10b-5(b)
(Schiliro)
FOURTH CLAIM FOR RELIEF
Violations of Securities Act Section 17(a)
(All Defendants)
FIFTH CLAIM FOR RELIEF
Violations of Exchange Act Section 13(a), 13(b)(2)(A) and 13(b)(2)(B)
of the Exchange Act and Rules 12b-20, 13a-1 and 13a-13 Thereunder
(UHP)
SIXTH CLAIM FOR RELIEF
Aiding and Abetting Violations of Exchange Act Section 13(a),
13(b)(2)(A), 13(b)2)B), and Rules 12b-20, 13a-1 and 13a-13
(Beplate and Schiliro)
SEVENTH CLAIM FOR RELIEF
Violation of Section 13(b)(5) of the Exchange Act and Exchange Act Rule 13b2-1
(Beplate and Schiliro)
EIGHTH CLAIM FOR RELIEF
Violations of Exchange Act Section 13(a) and Rule 13a-14 Thereunder
(Beplate)
NINTH CLAIM FOR RELIEF
Violations of Rule 13b2-2 of the Exchange Act
(Beplate and Schiliro)
TENTH CLAIM FOR RELIEF
Violations of Sarbanes-Oxley Act Section 304(a)
(Beplate)
ELEVENTH CLAIM FOR RELIEF
Violations of Exchange Act Section 16(a) and Rule 16a-3 Thereunder
(Beplate)"
https://www.sec.gov/files/litigation/complaints/2022/comp25413.pdf
๐Ÿ‘๏ธ0
Waverunners Waverunners 2 weeks ago
Please stop lying. It helps no one.

โ€œHowever, they put their name on Hemostyp when they declared it superior to the industry leader.โ€

And using this lie to support a false statement:

โ€œThey wouldn't do that if they weren't eventually going to approve it.โ€

I know this is just a message board and anything goes, but blatant lies have to be called out.

My hope is that UHP is on the right path going forward. But all these conspiracy theories, combined with lies are so unfortunate.

Hopefully, he is done posting in 2024.
If thatโ€™s the case, I look forward to reading the board in 2025 , when there are some REAL events to comment on.
๐Ÿ‘๏ธ0
trusttheman trusttheman 2 weeks ago
The one thing I can't stress enough is this from what I've heard from people who have used the band-aids. If you use one, you will never go back to the J&J crap bandages again. Essentially, they are worthless compared to the Hemostyp band-aid. Then of course you get into all the surgeries that will be using Hemostyp which will become the standard of care the second they are approved which we all hope will happen. All these delays are happening for a reason. Some will blame the company for the delays. I'm sure they could have done some things differently. However, make no mistake. The corrupt FDA is nothing but a puppet for J&J. That is one huge reason the new administration under Trump is going to clean house on them. J&J's bread and butter has always been band-aids. When people find out they have to use one Hemostyp band-aid, maybe a second if the cut gets wet instead of 10 to 15 J&J band-aids and the wound heals 3 to 4 times faster with a hemostyp band-aid, it causes extreme fear for even the biggest pharm company out there. They can say whatever they want. J&J is afraid. No matter now small the possibility is that they might not be able to obtain UEEC's product. They're afraid. The last move the FDA pulled proves that. As I said before. Absolute corruption asking for more abdominal surgeries when you had 4 years to do so. It's a slimy, corrupt tactic that they can get away with because of the simple fact we are a small OTC company. However, they put their name on Hemostyp when they declared it superior to the industry leader. They wouldn't do that if they weren't eventually going to approve it. If these delays weren't so painful I would be laughing my ass off that a little OTC company with a game changing product is scaring the biggest bully pharm company on the planet. J&J always talks tough. Saying they won't chase something. Historical, they always overpay. Just imagine what they will pay for a product that not only will eliminate Surgicrap but could potentially wipe out their band-aid market.
💤 1 😴 1
GetRch$lwly GetRch$lwly 2 weeks ago
Agree, wave and good point!. I don't think we will see any comment from the FDA other than an approval or denial when they finally feel they have enough information to make that decision.
๐Ÿ‘๏ธ0
Waverunners Waverunners 2 weeks ago
Thanks GR$. Yes, UHPs clinical trials absolutely showed superiority. That is definitely a fact.
This PR wisely notes that the UHP team made this clear to the FDA in their discussion.
That was smart. In the quote you have provided โ€œ the company (UHP)noted the results of its clinical trial.โ€ That is great.

In no way does this indicate that the FDA has given Hemostyp (CelluStat) a superior rating.
๐Ÿ‘๏ธ0
GetRch$lwly GetRch$lwly 2 weeks ago
Per UEEC's press release. They were the one to first use "superiority"

During the discussion, the company noted the results of its clinical trial involving 232 patients (of whom 118 were treated with its hemostatic gauze) that showed both non-inferiority and superiority for time to hemostasis using CelluSTAT (fka HemoStyp) relative to the standard of care and showed no evidence of heterogeneity of results across procedure categories, surgeons, or clinical sites, indicating both poolability and generalizability of study results.
๐Ÿ‘๏ธ0
JimmyRich JimmyRich 2 weeks ago
I think we have more opinions than facts.. fact is we donโ€™t have the information from the company that we need entirely and we are going off of hypotheses and I do think some of us have aspirations that are a bit too high but then again on this market nobody knows anything., Iโ€™ve seen totally useless pieces of shit run for no reason at all.. letโ€™s hope we go the right way and get the proper fda approval because that is how I would like to see it play out.. no scams no pumps no stories.. just facts and an approval that makes us class 3 because that is what we really need
๐Ÿ‘๏ธ0
Waverunners Waverunners 2 weeks ago
I almost made it to the end of 2024 without engaging with any more of this personโ€™s posts, but this is so inaccurate that I just canโ€™t help myself.

1. When did FDA give Hemostyp a superior rating. Trust says this twice.
โ€œ The FDA as I said gave this a superior rating.โ€

2. DBnews was not โ€œcompletely wrong โ€œ. Hemostyp (aka CelluStat) is a class 1 device that could be sold in retail.

3. It is not a class 3 device until it gets approved. It is a class 1 device. There was potential in this market but UHP decided to go all in on the PMA.

4. It didnโ€™t go to $2.45 due to a โ€œfast track announcement.โ€ It was an unprecedented surge based on pumpers and MM creating a huge Shorting opportunity (remember White Diamond)

5. $20-30 per share. Sounds good, but just a made up number. DBโ€™s numbers are far more realistic.

6. His Bandaid rant is hilarious. But he sure talks like an expert, though he has never bought or used the โ€œband-aid aspectโ€ of this product.โ€ Somehow he knows one would require up to 15 more band aids. Why didnโ€™t he spend $20 and buy the superior product? They were available to the general public yet he never bought (or used) a product heโ€™s invested in, yet he boldly states โ€œ The band-aid aspect of this product is going to put J&J in serious trouble if they don't get the productโ€

7. โ€œ The projected current value of the company when it was appraised was 4 to 900,000 million.โ€
4 to 900,000 million. What the heck.
$900,000,000,000.00
Thatโ€™s just wild.

8. The FDA conspiracy is odd. Iโ€™ll leave it at that.

Hoping for the best in 2025. To the posters asking intelligent questions and/or attempting to add a rational voice to this board, keep it up Please. Trust me, there are readers here that really do want to have those discussions. Itโ€™s just hard to get berated but the angry man.
๐Ÿ‘๏ธ0
JimmyRich JimmyRich 2 weeks ago
Thank you for the reply I appreciate the info.. definitely good news.. letโ€™s hope weโ€™re on the way
👍️ 1
JimmyRich JimmyRich 2 weeks ago
Nice post.. very informative
๐Ÿ‘๏ธ0
CHARLIESAN CHARLIESAN 2 weeks ago
The opinion was from a medical professional who is the smartest person I know. I think there has been commentary from board members who have stated that the approvals for Dental and Vets. were in place. A Annual Report a couple years back actually showed a $35,000 product sale for the only income stream I am aware of. I am not sure but the 35K sale of product may have been to a Dental operation. It was my understanding that these two approvals were obviously different from the in human surgical uses. IMO if they have these two approvals in place; the bottom worst case is far above the .05 cent range we now see. But I agree; the real hope is for the elements of our government not functioning in the public interest to be gone. Hope is in sight. Could we add a little "Joy"? LOL.
🤣 1
trusttheman trusttheman 2 weeks ago
Completely incorrect DBNews. This is a class 3 device. Almost impossible to get approved. They were already given a superior rating by the FDA to the only competitor for class 3 on the market. Which by the way is a pile of crap and was never FDA approved. Grandfathered in. I would be shocked if it didn't go to 3 to 5 dollars on approval. It went to $2.45 when they announced they were on the fast track program for the FDA. Which by the way obviously was a load of crap from the corrupt FDA who will soon have over half its criminal employees fired. I said from the beginning. 20 to 30 dollars if they get approval and sell the company. 4 to 6 billion for this product is fly sh!t for a major pharma company that gets this product. They will make that back in the first couple years. Oh and by the way. The band-aid aspect of this product is going to put J&J in serious trouble if they don't get the product. I know people that have used them. You use one of this companies band-aids. Stops bleeding. Heals the cut much faster. You don't use 7 to 15 more like you do with the regular band-aid crap. Believe me. J&J knows this. You are kidding yourself if you don't think they have stalled approval on this with the FDA. Their band-aid market will suffer massive losses to Hemosytp band-aids. Don't be fooled by the current share price. It's what happens when the FDA is corrupt, uses stalling techniques and the stock is on the pinks being heavily shorted. The FDA as I said gave this a superior rating. They can't stall forever. The projected current value of the company when it was appraised was 4 to 900,000 million. Sales price usually goes 6 to 8 times that. 4 dollar a share for each billion. 2 dollars a share would be if they couldn't get this to the finish line approval wise. Like I said. Take comfort in that the FDA firings are coming.
👍️ 3 🤣 1
JimmyRich JimmyRich 2 weeks ago
What is your opinion of the source that shared this opinion?? Obviously I would love for it to be the case because itโ€™s progress and any progress is welcomed.. thanks in advance
🤣 1
CHARLIESAN CHARLIESAN 2 weeks ago
I had an opinion stated to me that the FDA approvals already in place for Vet. and Dental usages were in the worst case of
some reasonable value. That seems logical as a worst case. Any opinions out there on this assumption??
🤣 1
DBnews DBnews 3 weeks ago
New to board. Been watching board for many years listening to all your opinions on this stock. I bought in at the beginning at .09 per share (about 40000) shares. Sold about 15000 over the years at .65 to .75. Got all my money back as the original purchase was a whim. I have seen all the speculations about a pot of gold at the end of the rainbow. I saw the stock hit over $2.00 per share, was thrilled, only to see it drop. Now its below what I paid for it so many years ago. Any idiot who thinks this is going to $5 or $10 per share on a buyout is not a real investor. If the FDA ever approves this, and I mean ever, we would be lucky to get $2.00. That would be OK for me. Stop saying it is worth so much.
๐Ÿ‘๏ธ0
Zorax Zorax 3 weeks ago
Looks like some shareholders are throwing in the towel.Got a link for that?
It's not for the faint of heart having to wait for the corrupt FDA...The FDA isn't corrupt,,, yet. It's their job and they do it well. The FDA waits on the uhp corp to deliver the proper paperwork. It's on the scam uhp to deliver the goods, they're the ones to blame, not the FDA. It's never been the FDA. Constant repeating it's someone else's fault doesn't make it true.

Just shows the company is a scam.
👍️ 3 👎️ 1 💥 3
Zorax Zorax 3 weeks ago
Nasdaq has never been considered ,,otcqb is what they have filed forThen that is NOT an uplisting. It is a forever pump lie for ceo's to claim they are uplisting when it's only paying a higher fee to otcm advertising service to get new 'initials' added to their name. Junk talk. Like this junk stock.
👍️ 1 💯 1
JimmyRich JimmyRich 3 weeks ago
We have no choice but to wait at this point weโ€™re this deep might as well go all the wayโ€ฆ but about yesterdays posts.. weโ€™re hardly heavily shorted no question
๐Ÿ‘๏ธ0
trusttheman trusttheman 3 weeks ago
Looks like some shareholders are throwing in the towel. It's not for the faint of heart having to wait for the corrupt FDA to give up with their nonsense. I can wait a little longer.
👺 1 😂 1
rodman rodman 3 weeks ago
Thanks for your work Trust! It its any consolation the short bashers only bash good stocks!
$5-$10+
๐Ÿ‘๏ธ0
trusttheman trusttheman 3 weeks ago
You can see here the way this stock is shorted and has been for a very long time.

https://www.otcshortreport.com/company/UEEC
👍 2
Chrism0000 Chrism0000 3 weeks ago
Heads must roll!!!!
๐Ÿ‘๏ธ0
Hoonigan Hoonigan 4 weeks ago
Wow someone needs some cash before Christmas that just got a ton of shares to sell at these low bargain prices and volume. It is a shame that they have to sell and dilute the market to get some cash. But it is a Great Christmas present buying opportunity! I will keep buying all day long at $.061 what a steal.

Looks like robot Santa loaded his sleigh up with stock too and is out doing some shenanigans!
๐Ÿ‘๏ธ0
JimmyRich JimmyRich 4 weeks ago
Very interesting I didnโ€™t know that again thanks for the info and letโ€™s hope this is moving us toward the uplisting..
๐Ÿ‘๏ธ0
rodman rodman 4 weeks ago
Actually closer to 35 then he gave 1+ million shares back to the company in partial payment of his SEC ruling. He then put 18 million into a grantor trust with a trustee empowered to control the trust assets so he basically divested himself of all but the 6.7 million.
Interesting!
๐Ÿ‘๏ธ0
JimmyRich JimmyRich 4 weeks ago
Thank you
๐Ÿ‘๏ธ0
GetRch$lwly GetRch$lwly 4 weeks ago
Based on my experience, I'm guessing this was done to clarify some questions related to the OTCQB uplift filing. This would also explain why something that normally takes 6 -8 weeks still hasn't been completed.
๐Ÿ‘๏ธ0
JimmyRich JimmyRich 4 weeks ago
Thoughts?? Didnโ€™t he own like 30 million + in shares?
๐Ÿ‘๏ธ0
rodman rodman 4 weeks ago
Former CEO filed and SEC required statement to indicate his percentage of ownership decreased. Not sure what the overall implication is but he now only controls 6,700,000 shares of UEEC.

https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=318767261&type=HTML&symbol=UEEC&cdn=bb1a4e05e3671da42927a9f4a730762f&companyName=United+Health+Products+Inc&formType=SC+13D%2FA&formDescription=%5BAmend%5D+General+statement+of+acquisition+of+beneficial+ownership&dateFiled=2024-12-04
๐Ÿ‘๏ธ0
JimmyRich JimmyRich 1 month ago
As usual very well said
๐Ÿ‘๏ธ0
JimmyRich JimmyRich 1 month ago
As usual very well said
๐Ÿ‘๏ธ0
dogooder dogooder 1 month ago
Nasdaq has never been considered ,,otcqb is what they have filed for, will it help,,maybe yes, maybe no,,but it won't hurt, they need to execute on the plan they have laid out, credibility is severely compromised, execution of the plan is the only way to regain trust in management.
👍️ 2
Zorax Zorax 1 month ago
I agree with you on the uplistinglmao. Uplisting to another tier of otcm advertising service isn't worth the electricity of typing it.
And if anyone is thinking nasdaq, this scam would need at least two years of trading at above 5 bucks. And at least 3 years of income. Not going to happen.

Ever...
๐Ÿ‘๏ธ0
Hoonigan Hoonigan 1 month ago
Amen and someone got some race gas in the engine when the shares dropped to this crazy low price. Hopefully everybody picked up the cheap shares, I know my trucks are full. Their no longer diluting the stock shares anymore with White Lion which is great news and going with more conventional investors to get this over the finish line as fast as they can. Thank the big man in the box seat that someone saw the light. I spent some time following the money trail and was going to do a post on it -- If you look at White Lion's companies they invest into with the same deal as UEEC got, their charts are identical to UEEC and the companies are all at the white flag lap and need some cash, then the stock goes to a record low and they need more cash. There's a pattern - high risk and reward investing or something else?

Time for more race gas and burnouts! We all know the trials are a slam dunk then cha-ching, cha-ching!

๐Ÿ‘๏ธ0
rodman rodman 1 month ago
Hell YES! UEEC has NOT been sitting on their hands! Time for a run up to .20 without White Lion and hopefully not a PPA!
$5-$10+
๐Ÿ‘๏ธ0
dogooder dogooder 1 month ago
I agree with you on the uplisting, it has been way longer than it should take, so hopefully there have been no issues with the filing and should be approved very soon, also hoping we get some news on upcoming surgeries, would be great to be able to complete them quickly once all the filings are done, lots of positives looking forward, I hope
👍 1
trusttheman trusttheman 1 month ago
That's a good point Dogooder. The tax strategy is very real this time of year. I also hope they will be uplisted next week from the pink sheets. So, you might be looking for shorts to get in all they can before the holiday. I've actually used the product. It's obscene how good it is. It's also laughable how bad Surgicrap is. However, sadly I have learned that the FDA doesn't care at all about saving lives. They are corrupt. All the care about is money and keeping their jobs. Much like the SEC. Thus, why this new administration is going to clean house on both of them.
👍️ 1